- Top Workplaces
- Kymera Therapeutics
Kymera Therapeutics
Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years. For more information about our science, pipeline and people, please visit www.kymeratx.com.
Purpose
Propelling our rigorous scientific approach is a relentless desire to improve—to expand the opportunity and application of our science, scale our capabilities to support a growing company, and build a culture that enables us to achieve what may have seemed impossible. Our shared values and a deep commitment to improving patients’ lives are the guiding principles that drive our work and connect our diverse and experienced teams to the mission of Kymera.
Vision
Reinvent the treatment of human disease.
Mission
Build a global medicines company that harnesses novel modalities to revolutionize healthcare.
Values
- Pioneer
- We are courageous, resilient and rigorous in our mission to improve patients’ lives through our revolutionary degrader medicines.
Company Snapshots
